HPC
ZBH icon

Hobart Private Capital’s Zimmer Biomet ZBH Stock Holding History

Hobart Private Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,277
Closed -$608K – 91
2021
Q3 		$608K Sell
4,277
-49
-1% -$7.21K 0.24% 59
2021
Q2 		$675K Sell
4,326
-251
-5% -$40.7K 0.28% 58
2021
Q1 		$711K Buy
+4,577
New +$709K 0.29% 52

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Hobart Private Capital's ZBH Position: Q4 2021 in Review

Hobart Private Capital sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 4,277 shares — an estimated $608K sold.

Hobart Private Capital first reported a position in ZBH in Q1 2021 and held it in 3 quarters. The position peaked at $711K in Q1 2021. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Hobart Private Capital reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Hobart Private Capital sold 4,277 Zimmer Biomet shares in Q4 2021, an estimated $608K.
  • Hobart Private Capital first reported a position in Zimmer Biomet in Q1 2021 and held it in 3 quarters.
  • Hobart Private Capital's Zimmer Biomet position peaked at $711K in Q1 2021.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Hobart Private Capital's 13F filing for Q4 2021, filed 11 Mar 2024.